ERBB2 and breast cancer: GDSC database [34] contains basal gene expression and drug response data for fifty BC cell lines belonging to different histological subtypes and five drugs (lapatinib, erlotinib, EKB-569, afatinib and CP724714) that target HER2 and/or EGFR tyrosine kinases.